Zymeworks (ZYME) Other Accumulated Expenses (2021)

Zymeworks (ZYME) reported Other Accumulated Expenses of $22000.0 for Q4 2021.

Zymeworks (ZYME) Other Accumulated Expenses (2021) Analysis & Trends

Zymeworks (ZYME) has 1 years of Other Accumulated Expenses data on file, last reported at $22000.0 in Q4 2021.

For the quarter ending Q4 2021, Other Accumulated Expenses changed N/A year-over-year to $22000.0; the trailing twelve-month figure through Dec 2021 stood at $22000.0 (changed N/A YoY), and the FY2021 full-year result was $22000.0, changed N/A from the prior year.
Other Accumulated Expenses was little changed at $22000.0 in Q4 2021.
In the past five years, Other Accumulated Expenses ranged from a high of $22000.0 in Q4 2021 to a low of $22000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Zymeworks	1.73 Bn	1.36 Bn	-

Download Data

Date	Value
Dec 31, 2021	22,000.00